Background: General adiposity is a well-known risk factor for cardiovascular disease. By contrast, the interconnection between high intra-pancreatic fat deposition and cardiovascular disease has been scantily investigated. This field-wide systematic review aimed to map the available evidence on cardiovascular disease according to the fat content of the pancreas.

Methods: A literature search using two electronic databases (MEDLINE and Embase) was conducted independently by two reviewers. Studies reporting on the association between intra-pancreatic fat deposition and cardiovascular disease in humans were included. Where meta-analysis was possible, data were pooled using a random-effects method.

Results: A total of 16 studies published between 1966 and 2024 were included. The most credible findings across domains of heart diseases, diseases of arteries, arterioles, and capillaries, as well as subclinical atherosclerosis provided supportive evidence of a positive relationship between high intra-pancreatic fat deposition and cardiovascular disease. Meta-analysis showed that high intra-pancreatic fat deposition was significantly associated with increased aortic intima-media thickness (mean difference: 0.19 mm; 95% confidence interval: 0.12-0.26; p < 0.001), increased carotid intima-media thickness (mean difference: 0.06 mm; 95% confidence interval: 0.03-0.08; p < 0.001), and increased vascular stiffness (mean difference: 167 cm/s; 95% confidence interval: 81-254; p < 0.001).

Conclusion: The accumulated evidence from more than 7000 people demonstrates a tangible connection of intra-pancreatic fat deposition with cardiovascular disease (especially, subclinical atherosclerosis). Purposely designed investigations of high intra-pancreatic fat deposition as an additional risk factor (independent of general adiposity) for cardiovascular disease are warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1111/obr.13914DOI Listing

Publication Analysis

Top Keywords

cardiovascular disease
24
intra-pancreatic fat
16
fat deposition
16
high intra-pancreatic
12
deposition cardiovascular
12
systematic review
8
cardiovascular
6
disease
6
fat
5
relationship fat
4

Similar Publications

The links between soil and water pollution and cardiovascular disease.

Atherosclerosis

March 2025

University Medical Center Mainz, Department of Cardiology at the Johannes Gutenberg University, Germany; German Cardiovascular Research Center (DZHK), Partner Site Rhine Main, Mainz, Germany.

Soil and water pollution represent significant threats to global health, ecosystems, and biodiversity. Healthy soils underpin terrestrial ecosystems, supporting food production, biodiversity, water retention, and carbon sequestration. However, soil degradation jeopardizes the health of 3.

View Article and Find Full Text PDF

Acute exacerbation of chronic obstructive pulmonary disease: An underestimated cardiovascular risk factor.

Eur J Intern Med

March 2025

INSERM, U1059, SAINBIOSE, Jean Monnet University, 42023, Saint-Etienne, France; Therapeutic and Vascular Medicine Department, University Hospital of Saint-Etienne, 42270, Saint-Etienne, France; INSERM, CIC 1408, 42023, Saint-Etienne, France.

View Article and Find Full Text PDF

Omega-3 index improves upon the pooled cohort equation in predicting risk for CVD.

J Clin Lipidol

February 2025

Fatty Acid Research Institute, Sioux Falls, SD, USA (Drs Tintle, Marchioli, and Harris); Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA (Dr Harris).

Background: Accurate predictive tools are crucial for identifying patients at increased risk for atherosclerotic cardiovascular disease (ASCVD). The Pooled Cohort Equation (PCE) is commonly used to predict 10-year risk for ASCVD, but its accuracy remains imperfect.

Objective: This study examined the extent to which the omega-3 index (O3I; the proportion of eicosapentaenoic acid+docosahexaenoic acid in erythrocyte membranes) improved the predictive capability of PCE.

View Article and Find Full Text PDF

The IL-6 axis in vascular inflammation: effects of IL-6 receptor blockade on vascular lesions from patients with giant-cell arteritis.

Ann Rheum Dis

March 2025

Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic (member of European Reference Network [ERN]-for rare diseases RITA), University of Barcelona, Centre de Recerca biomèdica (CRB)-CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Electronic address:

Objectives: Blocking interleukin (IL)-6-receptor with tocilizumab has been a major advance in the treatment of giant-cell arteritis (GCA), supporting a crucial role of IL-6 receptor signalling. However, nearly half of the patients are not able to maintain glucocorticoid- free remission with tocilizumab. The impact of tocilizumab on vascular lesions of GCA is largely unknown since conflicting results have been obtained by imaging.

View Article and Find Full Text PDF

Aims: Atrial fibrillation (AF) is a frequent comorbidity in heart failure (HF). We analysed factors associated with new-onset atrial fibrillation in patients with heart failure using linked real-world UK data from primary and secondary care, along with findings from genome-wide association studies.

Methods And Results: Among 163 174 participants with a diagnosis of HF (January 1998 to May 2016) from Clinical Practice Research Datalink (CPRD) and Hospital Episodes Statistics (HES), 111 595 participants had no previous history of AF (mean age 76.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!